N@N

Novogen Ltd (NASDAQ:NVGN), Down By 75.82% ($4.61) From $6.080 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bear

^{Published on 2012-11-29 07:42:54 - WOPRAI}
 

November 29, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, November 19th 2012 stating that Novogen Ltd (NASDAQ:NVGN) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=nvgn&id=329014

At the time this story was written, Novogen Ltd (NASDAQ:NVGN) is Down By $4.61 (75.82%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Novogen Ltd (NASDAQ:NVGN) - Novogen Limited and its subsidiaries engage in the discovery, development, manufacture, export, and marketing of pharmaceuticals and consumer health care products. Its anti-cancer products include Phenoxodiol, a phase III investigational drug for late stage, chemoresistant ovarian cancer and a Phase II clinical trial for prostate and cervical cancers; and Triphendiol, a Phase I completed signal transduction inhibitor for the treatment of cholangiocarcinoma or bile duct cancer, and stage IIB through stage IV malignant melanoma. The companys anti-cancer products also comprise NV-143, a derivative of triphendiol acting as investigational anti-cancer drug; NV-128, a pre-clinical development stage investigational cancer compound using various molecular mechanisms to promote the death of cancer cells; and GLYC-101, a topical gel formulation that stimulates and modulates the natural cascade of wound healing activities in various cell populations. Its consumer health care products consist of various dietary supplement products, such as Promensil and Trinovin that deliver standardized levels of isoflavones, including daidzein, genistein, formononetin, and biochanin. The company distributes its products through direct marketing in Australia, Canada, and the United Kingdom, as well as through third party distribution arrangements internationally. Novogen Limited was founded in 1994 and is headquartered in North Ryde, Australia.. There is a failure to deliver in shares of NVGN

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net